Review





Similar Products

exosomal protein markers cd9  (Proteintech)
96
Proteintech exosomal protein markers cd9
Characterization of mBMSC and Their EVs. A Flow cytometry histograms showing expression of surface markers. Cells were negative for hematopoietic markers CD14, CD19, CD34, and CD45 (< 0.5%) and positive for mesenchymal markers CD29, CD44, CD73, and CD90 (> 98%). Gray shading represents isotype controls; red lines represent specific antibody staining. B Representative images of lineage-specific staining after differentiation induction: Alizarin Red (osteogenesis), Alcian Blue (chondrogenesis), and Oil Red O (adipogenesis). Scale bars, 100 μm. C Transmission electron microscopy images of EVs showing typical morphology and size. Scale bars represent 0.5 μm (left) and 200 nm (right). D Nanoparticle tracking analysis illustrating extracellular vesicle size distribution and concentration, with a peak around 100 nm. E Western blot detection of typical <t>exosomal</t> markers <t>CD9,</t> CD63, and CD81, confirming vesicle identity
Exosomal Protein Markers Cd9, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/exosomal protein markers cd9/product/Proteintech
Average 96 stars, based on 1 article reviews
exosomal protein markers cd9 - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier
antibodies against exosomal markers cd9  (Proteintech)
96
Proteintech antibodies against exosomal markers cd9
Characterization of mBMSC and Their EVs. A Flow cytometry histograms showing expression of surface markers. Cells were negative for hematopoietic markers CD14, CD19, CD34, and CD45 (< 0.5%) and positive for mesenchymal markers CD29, CD44, CD73, and CD90 (> 98%). Gray shading represents isotype controls; red lines represent specific antibody staining. B Representative images of lineage-specific staining after differentiation induction: Alizarin Red (osteogenesis), Alcian Blue (chondrogenesis), and Oil Red O (adipogenesis). Scale bars, 100 μm. C Transmission electron microscopy images of EVs showing typical morphology and size. Scale bars represent 0.5 μm (left) and 200 nm (right). D Nanoparticle tracking analysis illustrating extracellular vesicle size distribution and concentration, with a peak around 100 nm. E Western blot detection of typical <t>exosomal</t> markers <t>CD9,</t> CD63, and CD81, confirming vesicle identity
Antibodies Against Exosomal Markers Cd9, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies against exosomal markers cd9/product/Proteintech
Average 96 stars, based on 1 article reviews
antibodies against exosomal markers cd9 - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier
exosome markers cd9 cd63 tsg101  (Proteintech)
96
Proteintech exosome markers cd9 cd63 tsg101
Characterization of mBMSC and Their EVs. A Flow cytometry histograms showing expression of surface markers. Cells were negative for hematopoietic markers CD14, CD19, CD34, and CD45 (< 0.5%) and positive for mesenchymal markers CD29, CD44, CD73, and CD90 (> 98%). Gray shading represents isotype controls; red lines represent specific antibody staining. B Representative images of lineage-specific staining after differentiation induction: Alizarin Red (osteogenesis), Alcian Blue (chondrogenesis), and Oil Red O (adipogenesis). Scale bars, 100 μm. C Transmission electron microscopy images of EVs showing typical morphology and size. Scale bars represent 0.5 μm (left) and 200 nm (right). D Nanoparticle tracking analysis illustrating extracellular vesicle size distribution and concentration, with a peak around 100 nm. E Western blot detection of typical <t>exosomal</t> markers <t>CD9,</t> CD63, and CD81, confirming vesicle identity
Exosome Markers Cd9 Cd63 Tsg101, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/exosome markers cd9 cd63 tsg101/product/Proteintech
Average 96 stars, based on 1 article reviews
exosome markers cd9 cd63 tsg101 - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier
positive markers  (Proteintech)
96
Proteintech positive markers
Characterization of mBMSC and Their EVs. A Flow cytometry histograms showing expression of surface markers. Cells were negative for hematopoietic markers CD14, CD19, CD34, and CD45 (< 0.5%) and positive for mesenchymal markers CD29, CD44, CD73, and CD90 (> 98%). Gray shading represents isotype controls; red lines represent specific antibody staining. B Representative images of lineage-specific staining after differentiation induction: Alizarin Red (osteogenesis), Alcian Blue (chondrogenesis), and Oil Red O (adipogenesis). Scale bars, 100 μm. C Transmission electron microscopy images of EVs showing typical morphology and size. Scale bars represent 0.5 μm (left) and 200 nm (right). D Nanoparticle tracking analysis illustrating extracellular vesicle size distribution and concentration, with a peak around 100 nm. E Western blot detection of typical <t>exosomal</t> markers <t>CD9,</t> CD63, and CD81, confirming vesicle identity
Positive Markers, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/positive markers/product/Proteintech
Average 96 stars, based on 1 article reviews
positive markers - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier
exosomal markers cd9  (Proteintech)
96
Proteintech exosomal markers cd9
Characterization of mBMSC and Their EVs. A Flow cytometry histograms showing expression of surface markers. Cells were negative for hematopoietic markers CD14, CD19, CD34, and CD45 (< 0.5%) and positive for mesenchymal markers CD29, CD44, CD73, and CD90 (> 98%). Gray shading represents isotype controls; red lines represent specific antibody staining. B Representative images of lineage-specific staining after differentiation induction: Alizarin Red (osteogenesis), Alcian Blue (chondrogenesis), and Oil Red O (adipogenesis). Scale bars, 100 μm. C Transmission electron microscopy images of EVs showing typical morphology and size. Scale bars represent 0.5 μm (left) and 200 nm (right). D Nanoparticle tracking analysis illustrating extracellular vesicle size distribution and concentration, with a peak around 100 nm. E Western blot detection of typical <t>exosomal</t> markers <t>CD9,</t> CD63, and CD81, confirming vesicle identity
Exosomal Markers Cd9, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/exosomal markers cd9/product/Proteintech
Average 96 stars, based on 1 article reviews
exosomal markers cd9 - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier
exosomal marker proteins cd 9  (Proteintech)
96
Proteintech exosomal marker proteins cd 9
miR-146a-5p deficiency facilitates the osteoclastic differentiation of RAW264.7 cells in vitro . (A) Heat map diagram of the differential expression of <t>exosomal</t> miRNAs identified by miRNA microarray analysis. (B) Expression of osteoclastic-associated genes ( NFATC1 , CTSK , and TRAP ) in RAW264.7 cells transfected with miR-146a-5p mimics (Mimic group), control mimics (Ctr Mimic group), inhibitor (Inhi group), and control inhibitor (Ctr Inhi group) (n = 6; * P < 0.05). (C) Expression of NFATC1, CTSK, and CD40L/CD154 protein levels in RAW264.7 cells (Mimic, Ctr Mimic, Inhi, and Ctr Inhi group) (a) . Relative protein expression was quantified by ImageJ software (b) (n = 3; * P < 0.05). (D) TRAP staining of RAW264.7 cells (Mimic, Ctr Mimic, Inhi, and Ctr Inhi groups). * P < 0.05.
Exosomal Marker Proteins Cd 9, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/exosomal marker proteins cd 9/product/Proteintech
Average 96 stars, based on 1 article reviews
exosomal marker proteins cd 9 - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier
antibodies against exosome markers cd9  (Proteintech)
96
Proteintech antibodies against exosome markers cd9
miR-146a-5p deficiency facilitates the osteoclastic differentiation of RAW264.7 cells in vitro . (A) Heat map diagram of the differential expression of <t>exosomal</t> miRNAs identified by miRNA microarray analysis. (B) Expression of osteoclastic-associated genes ( NFATC1 , CTSK , and TRAP ) in RAW264.7 cells transfected with miR-146a-5p mimics (Mimic group), control mimics (Ctr Mimic group), inhibitor (Inhi group), and control inhibitor (Ctr Inhi group) (n = 6; * P < 0.05). (C) Expression of NFATC1, CTSK, and CD40L/CD154 protein levels in RAW264.7 cells (Mimic, Ctr Mimic, Inhi, and Ctr Inhi group) (a) . Relative protein expression was quantified by ImageJ software (b) (n = 3; * P < 0.05). (D) TRAP staining of RAW264.7 cells (Mimic, Ctr Mimic, Inhi, and Ctr Inhi groups). * P < 0.05.
Antibodies Against Exosome Markers Cd9, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies against exosome markers cd9/product/Proteintech
Average 96 stars, based on 1 article reviews
antibodies against exosome markers cd9 - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier

Image Search Results


Characterization of mBMSC and Their EVs. A Flow cytometry histograms showing expression of surface markers. Cells were negative for hematopoietic markers CD14, CD19, CD34, and CD45 (< 0.5%) and positive for mesenchymal markers CD29, CD44, CD73, and CD90 (> 98%). Gray shading represents isotype controls; red lines represent specific antibody staining. B Representative images of lineage-specific staining after differentiation induction: Alizarin Red (osteogenesis), Alcian Blue (chondrogenesis), and Oil Red O (adipogenesis). Scale bars, 100 μm. C Transmission electron microscopy images of EVs showing typical morphology and size. Scale bars represent 0.5 μm (left) and 200 nm (right). D Nanoparticle tracking analysis illustrating extracellular vesicle size distribution and concentration, with a peak around 100 nm. E Western blot detection of typical exosomal markers CD9, CD63, and CD81, confirming vesicle identity

Journal: Stem Cell Research & Therapy

Article Title: Protective effects of mouse bone marrow mesenchymal stem cell-derived extracellular vesicles on radiation-induced epididymal cells damage via USP44/RBM14 axis

doi: 10.1186/s13287-025-04782-9

Figure Lengend Snippet: Characterization of mBMSC and Their EVs. A Flow cytometry histograms showing expression of surface markers. Cells were negative for hematopoietic markers CD14, CD19, CD34, and CD45 (< 0.5%) and positive for mesenchymal markers CD29, CD44, CD73, and CD90 (> 98%). Gray shading represents isotype controls; red lines represent specific antibody staining. B Representative images of lineage-specific staining after differentiation induction: Alizarin Red (osteogenesis), Alcian Blue (chondrogenesis), and Oil Red O (adipogenesis). Scale bars, 100 μm. C Transmission electron microscopy images of EVs showing typical morphology and size. Scale bars represent 0.5 μm (left) and 200 nm (right). D Nanoparticle tracking analysis illustrating extracellular vesicle size distribution and concentration, with a peak around 100 nm. E Western blot detection of typical exosomal markers CD9, CD63, and CD81, confirming vesicle identity

Article Snippet: Exosomal protein markers CD9 (Proteintech, #20,597–1-AP, 1:2000), CD81 (Proteintech, #27,855–1-AP, 1:2000) and CD63 (Proteintech, #67,605–1-Ig, 1:5000) were detected by Western blotting.

Techniques: Flow Cytometry, Expressing, Staining, Transmission Assay, Electron Microscopy, Concentration Assay, Western Blot

miR-146a-5p deficiency facilitates the osteoclastic differentiation of RAW264.7 cells in vitro . (A) Heat map diagram of the differential expression of exosomal miRNAs identified by miRNA microarray analysis. (B) Expression of osteoclastic-associated genes ( NFATC1 , CTSK , and TRAP ) in RAW264.7 cells transfected with miR-146a-5p mimics (Mimic group), control mimics (Ctr Mimic group), inhibitor (Inhi group), and control inhibitor (Ctr Inhi group) (n = 6; * P < 0.05). (C) Expression of NFATC1, CTSK, and CD40L/CD154 protein levels in RAW264.7 cells (Mimic, Ctr Mimic, Inhi, and Ctr Inhi group) (a) . Relative protein expression was quantified by ImageJ software (b) (n = 3; * P < 0.05). (D) TRAP staining of RAW264.7 cells (Mimic, Ctr Mimic, Inhi, and Ctr Inhi groups). * P < 0.05.

Journal: Frontiers in Cellular and Infection Microbiology

Article Title: Gingipains disrupt bone homeostasis via dual regulation of osteogenesis and osteoclastogenesis through exosomal miR-146a-5p/TRAF6 signaling

doi: 10.3389/fcimb.2025.1614126

Figure Lengend Snippet: miR-146a-5p deficiency facilitates the osteoclastic differentiation of RAW264.7 cells in vitro . (A) Heat map diagram of the differential expression of exosomal miRNAs identified by miRNA microarray analysis. (B) Expression of osteoclastic-associated genes ( NFATC1 , CTSK , and TRAP ) in RAW264.7 cells transfected with miR-146a-5p mimics (Mimic group), control mimics (Ctr Mimic group), inhibitor (Inhi group), and control inhibitor (Ctr Inhi group) (n = 6; * P < 0.05). (C) Expression of NFATC1, CTSK, and CD40L/CD154 protein levels in RAW264.7 cells (Mimic, Ctr Mimic, Inhi, and Ctr Inhi group) (a) . Relative protein expression was quantified by ImageJ software (b) (n = 3; * P < 0.05). (D) TRAP staining of RAW264.7 cells (Mimic, Ctr Mimic, Inhi, and Ctr Inhi groups). * P < 0.05.

Article Snippet: Exosomal marker proteins CD 9 (proteintech, 20597-1-AP, 1:4000) and CD 81 (proteintech, 27855-1- AP, 1:2000) were examined by western blot.

Techniques: In Vitro, Quantitative Proteomics, Microarray, Expressing, Transfection, Control, Software, Staining